Hims & Hers stock tanks as Amazon debuts fixed pricing for hair-loss and erectile-dysfunction drugs

The telehealth company’s share price fell by double digits after the e-commerce giant upped the competition for direct-to-consumer marketplaces.

Hims & Hers Health, a telehealth service for clients to access healthcare and prescriptions from home, is seeing its stock take a steep dive on Thursday, just after Amazon announced updates to a strikingly similar service for Prime members.